NORML files an amicus brief urging the Sixth Circuit to reconsider invalidating marijuana business contracts, warning of consumer safety risks.

Curaleaf lifted its hostile offer for Aurora Cannabis to $5 per share, saying its proposal relied on public data and calling for a fair process for shareholders.

Curaleaf launched a hostile takeover offer for Aurora, moving the proposal directly to investors. Here’s what that could mean for product supply, delivery compliance, and DMV consumers.

New Jersey regulators are appealing a court loss to Curaleaf in a labor dispute. Here’s why delivery operators and consumers should watch the labor–licensing link.

Aurora told investors to reject Curaleaf’s unsolicited $272M hostile bid and formed a special committee. Here’s what it could mean for delivery models, investors, and the DMV market.

Index inclusion can boost visibility, liquidity, and capital access. Here’s how it may ripple across marijuana delivery stocks, cannabis apps, and DMV entrepreneurs.

A new appellate decision threatens the enforceability of cannabis deals in federal court—and it reshapes leverage, drafting strategy, and risk for delivery, retail, and investors.

Curaleaf urges Aurora investors to accept a $4-per-share hostile offer it says carries a 45% VWAP premium; Aurora calls the bid inadequate and risky. Here’s the business impact and DMV angle.

A Sixth Circuit ruling says federal illegality blocks enforcement of a Michigan cannabis supply deal. Here’s how that risk touches delivery contracts in DC, Maryland, and Virginia.

Institutional money is knocking on cannabis again. Here’s how delivery operators and DMV founders can thrive—without losing the company to predatory term sheets.

Curaleaf’s hostile push for Aurora isn’t just about a headline premium. It spotlights cash, debt, and market position — and how consolidation could reshape delivery.

Congress’s hemp pause, closing arguments in the rescheduling case, a major M&A rebuff, and compliance warnings headline the week’s cannabis policy and business shifts.

Aurora says it is debt‑free with CA$149M cash and urges shareholders to reject Curaleaf’s hostile $4‑per‑share offer, warning the deal discounts assets and shifts risk.

Aurora told shareholders not to tender to Curaleaf’s hostile bid and signaled it’s weighing alternatives, sharpening focus on valuation, upside sharing, and voting control.